Urinary incontinence
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Literate women; older than 18 years; with body mass index (BMI) > 30 kg/m2; who agree on participating on the study through signing the TCLE; who are not in the gestation period and postpartum; self reporting urinary incontinence in the last four weeks (measured by the score > 0 in the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF); who are not engaged in a weight loss treatment It consists of a questionnaire that was translated and validated to Portuguese by Tamanini et al which evaluates the symptoms, UI severity and the impact that UI has in the woman life quality (QoL). It is a short questionnaire that aims to facilitate the data comparison of different studies and to enable a more consistent and unified evaluation of the UI symptoms and its impact on QoL.
Exclusion criteria
Exclusion criteria: Women who do not want to keep participating in the research; withdrawn their consent to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome: Assess self-reported urinary incontinence and symptom severity. Evaluated by the ICIQ-SF score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Assess the adherence. A digital diary will be used in which participants will take note about their frequency of the exercises. This diary will be attached to the informative leaflet they will receive in the very first session. The diary will be digitally collected by the physiotherapist every week. ;Assess the treatment satisfaction. Will be measured by the Visual Analogic Scale (VAS) which consists in an estimate in numerical scale in which 0 represents no discomfort and 10 the maximum imaginable discomfort. Furthermore, some questions will be asked such as “Was there any discomfort? Which one?”, “Would you consider using this treatment again?”, “Would you indicate this treatment to other people?”, “Would you consider looking for other treatment?”, “Are there barriers to the treatment?”. | — |
Countries
Brazil
Contacts
Universidade de São Paulo